News Covis finally pulls preterm birth drug Makena from market Following FDA recommendation for withdrawal, Covid finally pulls premature birth drug Makena.
News Mesoblast lifts off as FDA agrees to review GvHD drug again Regulator has started a priority review of the cell therapy, with a decision due by 2nd August.
News Sought-after obesity drug Wegovy backed for NHS use Use is restricted to two years in patients enrolled in NHS weight management services.
News FDA removes leash from Verzenio in early breast cancer Drug can now be used as adjuvant therapy without Ki-67 testing, taking a brake off prescribing.
News An aura of adult migraine hope as NICE recommends Vyepti Lundbeck’s eptinezumab receives NICE recommendation for the prevention of migraine in adults.
News Dismay as UK raises clawback rate on NHS drug spending Rise in rate to 27.5% from 1st April will damage the UK economy, claim senior industry figures.
News Simple blood test could aid in global TB fight A blood test for tuberculosis that can distinguish between dormant and active infections has shown promise in a clinical trial.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
